Alumni.

Alumni hold a special place in the heart of our lab, Their diverse journeys post-lab demonstrate the versatility of skills and knowledge they acquired during their time with us. We are proud of our lab alumni who, as future researchers, continue to explore and discover.

Daniel J. (DJ) Doty, BS

Sr. Laboratory Specialist 2020- 2023

Current Position:

Sr. Laboratory Specialist, University of Utah

Feroz Ahmed Shaik

Postdoctoral Fellow 2020-2023

Research Emphasis:

Identifying Small Molecules Inhibiting Toll-like Receptor (TLR) Mediated Signaling and Inflammation.

Current Position:

Scientist at Popvax

Shaheer Ahmad, PhD

Postdoctoral Fellow 2020-2021

Research Emphasis:

Role of TNIP1 in SLE

Current Position:

Postdoctoral Fellow at La Jolla Institute for Immunology

Peter Daniels

Undergraduate Student 2017- 2018

Research Emphasis:

TNIP1 signaling and apoptosis

Current Position: Medical Student at VCU School of Medicine

Jeeba (Kuriakose) Bellot, PhD

Postdoctoral Fellow 2011-2017

Research Emphasis:

Role of patrolling monocytes in SLE

Publication:

Patrolling monocytes promote the pathogenesis of early lupus-like glomerulonephritis

A phospho-tyrosine-based signaling module using SPOP, CSK, and LYN controls TLR-induced IRF activity

SHARPIN controls the development of regulatory T cells

Current Position:

Associate Director Flow Cytometry and QC Assay Development at Immatics

Sirish Ippagunta, PhD

Postdoctoral Fellow 2010-2015

Research Emphasis:

TLR drug development, cellular pathogenesis of psoriasis

Publication:

Identification of Toll-like receptor signaling inhibitors based on selective activation of hierarchically acting signaling proteins

Triaryl Pyrazole Toll-Like Receptor Signaling Inhibitors: Structure-Activity Relationships Governing Pan- and Selective Signaling Inhibitors

Keratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function

Patrolling monocytes promote the pathogenesis of early lupus-like glomerulonephritis

Current Position:

Associate Professor at AIIMS (All India Institute of Medical Sciences, New Delhi)

Kazuki Tawaratsumida, PhD

Postdoctoral Fellow 2010-2016

Research Emphasis:

Molecular mechanisms of signal transduction, Influenza host- pathogen interaction

Publication:

Quantitative proteomic analysis of the influenza A virus nonstructural proteins NS1 and NS2 during natural cell infection identifies PACT as an NS1 target protein and antiviral host factor.

Identification of Toll-like receptor signaling inhibitors based on selective activation of hierarchically acting signaling proteins

A phospho-tyrosine-based signaling module using SPOP, CSK, and LYN controls TLR-induced IRF activity

Current Position:

Research Associate Haecker Lab

Vandana Chaturvedi, PhD

Postdoctoral Fellow 2010-2013

Research Emphasis:

Role of Sharpin in T-cell differentiation

Publication:

SHARPIN controls the development of regulatory T cells.

Hematopoietic progenitor cell lines with myeloid and lymphoid potential

Current Position:

Scientist at Sana Biotechnology, Seattle

Juan P. Giraldo-Vela, PhD

Postdoctoral Fellow 2010-2012

(Redecke Lab)

Research Emphasis:

Identification of novel components of the T-cell receptor signaling pathway

Publication:

The E3 ubiquitin ligase mind bomb-2 (MIB2) protein controls B-cell CLL/lymphoma 10 (BCL10)-dependent NF-κB activation.

Current Position:

Infection Prevention Surveillance Analyst at Advocate Aurora Health

David Achila, PhD

Postdoctoral Fellow 2013-2015

Research Emphasis:

TNIP1 signaling and apoptosis

Current Position:

Manager, Quality Control Operations, CAR-T Manufacturing Cell Therapy at Bristol-Myers Squibb

Rohan Keshwara, PhD, CMPP

Undergraduate Student 2009

(Redecke Lab)

Research Emphasis:

Identify novel components of the T-cell receptor (TCR) signaling pathway

Current Position:

Senior Manager, Worldwide Publications (Hematology/Cell Therapy) at Bristol Myers Squibb

Cinthia Stempin, PhD

Postdoctoral Fellow 2008-2010

(Redecke Lab)

Research Emphasis:

Identification of novel components of the T-cell receptor signaling pathway

Publication:

The E3 ubiquitin ligase mind bomb-2 (MIB2) protein controls B-cell CLL/lymphoma 10 (BCL10)-dependent NF-κB activation.

Current Position:

Senior Researcher

CONICET Centre for Research in Clinical Biochemistry and Immunology (CIBICI)

Cordoba, Argentina

Liying Chi, MD

Sr Research Technologist 2008-2013 (Redecke Lab)

Publication:

The E3 ubiquitin ligase mind bomb-2 (MIB2) protein controls B-cell CLL/lymphoma 10 (BCL10)-dependent NF-κB activation.

Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lung.

NIK prevents the development of hypereosinophilic syndrome-like disease in mice independent of IKKα activation.

Current Position:

Sr Research Technologist St Jude Children’s Research Hospital, Memphis

Ruiqiong Wu, PhD

Associate Scientist 2008-2019

Research Emphasis:

Identification of novel components of the T-cell receptor signaling pathway

Publication:

A phospho-tyrosine-based signaling module using SPOP, CSK, and LYN controls TLR-induced IRF activity.

Patrolling monocytes promote the pathogenesis of early lupus-like glomerulonephritis.

Hematopoietic progenitor cell lines with myeloid and lymphoid potential.

A20-binding inhibitor of NF-kappaB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein beta activation and protects from inflammatory disease

Current Position:

Associate Scientist St Jude Children’s Research Hospital

Van Phan

Undergraduate Student 2009- 2013

Research Emphasis:

Molecular mechanisms of nfluenza host- pathogen interaction

Publication:

Quantitative proteomic analysis of the influenza A virus nonstructural proteins NS1 and NS2 during natural cell infection identifies PACT as an NS1 target protein and antiviral host factor.

Current Position:

Medical Student

Kim LeMessurier, PhD

Postdoctoral Fellow 2007-2011

(Redecke Lab)

Research Emphasis:

Host-pathogen interaction in Pneumoccal Disease

Publication:

Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lung.

Inhibition of T cells provides protection against early invasive pneumococcal disease.

Current Position:

Lead Scientist at Children's GMP LLC/St. Jude Children's Research Hospital

Jennifer Hobbs, PhD

Postdoctoral Fellow 2007-2010

Research Emphasis:

Signaling via TRAF family members

Current Position:

Senior Vice President for Administration, Chief of Staff at The New School, New York

Jingran Zhou, MD, PhD

Postdoctoral Fellow 2006-2012

Research Emphasis:

Deciphering the function of TNIP1 (ABIN1)

Publication:

A20-binding inhibitor of NF-kappaB (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein beta activation and protects from inflammatory disease

Patrolling monocytes promote the pathogenesis of early lupus-like glomerulonephritis

Sadly, Jingran passed away. She touched all of our lives profoundly and we miss her dearly.

Rafijul Bari, PhD

Postdoctoral Fellow 2006-2007

(Redecke Lab)

Research Emphasis:

CD28 receptor signaling

Current Position:

Director, Research and Early DevelopmentDirector, Research and Early Development

Celularity Inc.

THE HAECKER LAB

Innate Immunity | SignAl Transduction | Drug Development

Alumni.

THE HAECKER LAB

Innate Immunity | SignAl Transduction | Drug Development